Pfizer compresses as J&J expands ops structure

Pfizer's new CEO Ian Read has flattened the drug giant's org chart, eliminating the global head level. Unit heads will report to him instead, to speed decision-making. Tony Maddaluna will take over global manufacturing early next year when Nat Ricciardi retires. Meanwhile, J&J head Bill Weldon has added a layer at the board level. Sheri McCoy, currently global chairman for the pharma division, will become a vice chairman for the executive committee. She's being groomed as a potential successor to Weldon and will sit atop the manufacturing and quality-control overhaul at McNeil. Article | Story

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.